Pub Date : 2025-11-29DOI: 10.1016/j.tice.2025.103256
Mariana de Oliveira Viana Veras , Fátima Regina Nunes de Sousa , Conceição Silva Martins , Gildênio Estevam Freire , Ana Beatriz Graça Duarte , Thâmara Manoela Marinho Bezerra , Yves Ramos Costa Beviláqua , Stephany Ellen de Castro , Matheus Brandão dos Santos Lopes , Rosemayre Souza Freire , Pierre Basílio Almeida Fechine , Abrahão Cavalcante Gomes de Souza Carvalho , Paula Goes , Mirna Marques Bezerra , Renata Ferreira Carvalho Leitão
Magnesium-based biomaterials have emerged as promising candidates for bone regeneration due to their biodegradability and favorable mechanical properties. This study investigated the effects of Magnesium alloys without (Mg1) and with (Mg2) calcium phosphate coating on osteoblast viability and activation. The physical structure of the alloys was analyzed by surface characterization, mechanical testing, and biodegradation assays. Biological performance was evaluated through MTT and MTS assays for cell viability and proliferation, quantification of alkaline phosphatase activity at 24 h, 7, and 15 days, and mineralization by Von Kossa staining, after 21 days. Cell morphology and apoptosis were assessed using fluorescence microscopy and immunostaining for caspase 3 and 9, while protein expression of BMP-2, OPG, and RANK-L was also investigated by immunostaining. The results demonstrated a significant increase in viable cells in both Mg1 and Mg2 groups after 24 and 48 h. Enhanced mineralization and a significant increase in alkaline phosphatase activity were observed in the Mg2 group. Both Mg1 and Mg2 groups exhibited a similar reduction in caspases 3 and 9 expression, indicating cell survival despite morphological changes. Furthermore, osteoblasts cultured on both alloys showed greater expression of BMP-2 and OPG, compared to the DMEM group. Taken together, these findings highlight the potential of calcium phosphate-coated magnesium alloy as a novel approach for bone restoration in the future.
{"title":"In vitro osteogenic potential of magnesium alloy without and with calcium phosphate coating","authors":"Mariana de Oliveira Viana Veras , Fátima Regina Nunes de Sousa , Conceição Silva Martins , Gildênio Estevam Freire , Ana Beatriz Graça Duarte , Thâmara Manoela Marinho Bezerra , Yves Ramos Costa Beviláqua , Stephany Ellen de Castro , Matheus Brandão dos Santos Lopes , Rosemayre Souza Freire , Pierre Basílio Almeida Fechine , Abrahão Cavalcante Gomes de Souza Carvalho , Paula Goes , Mirna Marques Bezerra , Renata Ferreira Carvalho Leitão","doi":"10.1016/j.tice.2025.103256","DOIUrl":"10.1016/j.tice.2025.103256","url":null,"abstract":"<div><div>Magnesium-based biomaterials have emerged as promising candidates for bone regeneration due to their biodegradability and favorable mechanical properties. This study investigated the effects of Magnesium alloys without (Mg1) and with (Mg2) calcium phosphate coating on osteoblast viability and activation. The physical structure of the alloys was analyzed by surface characterization, mechanical testing, and biodegradation assays. Biological performance was evaluated through MTT and MTS assays for cell viability and proliferation, quantification of alkaline phosphatase activity at 24 h, 7, and 15 days, and mineralization by Von Kossa staining, after 21 days. Cell morphology and apoptosis were assessed using fluorescence microscopy and immunostaining for caspase 3 and 9, while protein expression of BMP-2, OPG, and RANK-L was also investigated by immunostaining. The results demonstrated a significant increase in viable cells in both Mg1 and Mg2 groups after 24 and 48 h. Enhanced mineralization and a significant increase in alkaline phosphatase activity were observed in the Mg2 group. Both Mg1 and Mg2 groups exhibited a similar reduction in caspases 3 and 9 expression, indicating cell survival despite morphological changes. Furthermore, osteoblasts cultured on both alloys showed greater expression of BMP-2 and OPG, compared to the DMEM group. Taken together, these findings highlight the potential of calcium phosphate-coated magnesium alloy as a novel approach for bone restoration in the future.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103256"},"PeriodicalIF":2.5,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145678548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.tice.2025.103252
Yi Liu , Yong Zeng , Mingyan Zhu , Changlong Cui , Lin Liao
Venous thromboembolism (VTE) is one of the leading causes of cardiovascular-related mortality worldwide. Its pathogenesis is complex, and current treatment strategies centered on anticoagulation face challenges such as high bleeding risks and limited efficacy in dissolving established thrombi. In recent years, research in the field of VTE has increasingly focused on the "inflammation-thrombosis" interaction, with macrophages emerging as a central regulator in this process, highlighting the growing importance of related studies. Through dynamic phenotypic polarization into pro-inflammatory M1 and anti-inflammatory M2 states, macrophages contribute to both thrombus formation and resolution. In the early stages of thrombogenesis, M1 macrophages establish a pro-inflammatory milieu by secreting chemokines, promoting leukocyte infiltration, enhancing platelet activation, and facilitating fibrin deposition, ultimately contributing to thrombus stabilization. Conversely, M2 macrophages play a central role in thrombus resolution by secreting matrix metalloproteinases (MMPs) and cytokines that promote fibrinolysis and endothelial repair. These polarization states are tightly regulated by hypoxia, metabolic reprogramming, and intercellular signals from endothelial cells, platelets, and neutrophils, forming an intricate multicellular regulatory network. Additionally, macrophages engage in exosome-mediated communication and immunomodulation, further amplifying thrombus-associated inflammation and vascular remodeling. Targeting macrophage polarization—particularly enhancing the M2 phenotype or disrupting chemotactic signaling pathways—has shown promise in reducing thrombus burden in preclinical models. Understanding the spatial-temporal heterogeneity of macrophage subsets and their interactions with other cell types may uncover novel therapeutic targets. This review summarizes current advances in macrophage biology in VTE, emphasizing their dual functional roles and regulatory networks. A better understanding of macrophage-driven immune-thrombotic crosstalk holds potential to refine current treatments beyond anticoagulation and to develop precision immunotherapies for VTE.
{"title":"Core regulatory mechanisms of macrophage dynamic polarization and multicellular interaction networks in driving venous thromboembolism","authors":"Yi Liu , Yong Zeng , Mingyan Zhu , Changlong Cui , Lin Liao","doi":"10.1016/j.tice.2025.103252","DOIUrl":"10.1016/j.tice.2025.103252","url":null,"abstract":"<div><div>Venous thromboembolism (VTE) is one of the leading causes of cardiovascular-related mortality worldwide. Its pathogenesis is complex, and current treatment strategies centered on anticoagulation face challenges such as high bleeding risks and limited efficacy in dissolving established thrombi. In recent years, research in the field of VTE has increasingly focused on the \"inflammation-thrombosis\" interaction, with macrophages emerging as a central regulator in this process, highlighting the growing importance of related studies. Through dynamic phenotypic polarization into pro-inflammatory M1 and anti-inflammatory M2 states, macrophages contribute to both thrombus formation and resolution. In the early stages of thrombogenesis, M1 macrophages establish a pro-inflammatory milieu by secreting chemokines, promoting leukocyte infiltration, enhancing platelet activation, and facilitating fibrin deposition, ultimately contributing to thrombus stabilization. Conversely, M2 macrophages play a central role in thrombus resolution by secreting matrix metalloproteinases (MMPs) and cytokines that promote fibrinolysis and endothelial repair. These polarization states are tightly regulated by hypoxia, metabolic reprogramming, and intercellular signals from endothelial cells, platelets, and neutrophils, forming an intricate multicellular regulatory network. Additionally, macrophages engage in exosome-mediated communication and immunomodulation, further amplifying thrombus-associated inflammation and vascular remodeling. Targeting macrophage polarization—particularly enhancing the M2 phenotype or disrupting chemotactic signaling pathways—has shown promise in reducing thrombus burden in preclinical models. Understanding the spatial-temporal heterogeneity of macrophage subsets and their interactions with other cell types may uncover novel therapeutic targets. This review summarizes current advances in macrophage biology in VTE, emphasizing their dual functional roles and regulatory networks. A better understanding of macrophage-driven immune-thrombotic crosstalk holds potential to refine current treatments beyond anticoagulation and to develop precision immunotherapies for VTE.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103252"},"PeriodicalIF":2.5,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.tice.2025.103236
Jie Liu , Yuan-Yuan Xu , Tian-Ye Gao
Background
Diabetic kidney disease (DKD) is a severe microvascular complication, and ferroptosis is a major contributor to its pathogenesis. This study investigated the protective effects of Qingyu formula (QYF), a traditional Chinese medicine prescription, against ferroptosis in high glucose-induced renal injury.
Methods
In vitro, human renal tubular cells (human kidney 2 [HK-2]) under high glucose conditions were treated with QYF. In vivo, the induced diabetic mice received QYF interventions. Biochemical and molecular assays assessed cell viability, oxidative stress, ferroptosis markers (Fe²⁺, glutathione [GSH], malondialdehyde) and nuclear factor erythroid 2-related factor 2/solute carrier family 7 member 11/glutathione peroxidase 4 (Nrf2/SLC7A11/GPX4) pathway activity.
Results
Qingyu formula enhanced cell viability and reduced reactive oxygen species in high glucose-treated HK-2 cells. It mitigated ferroptosis by decreasing Fe²⁺ accumulation and increasing GSH levels both in vivo and in vitro. Mechanistically, QYF upregulated GPX4, Nrf2 and SLC7A11. In diabetic mice, it improved metabolic parameters and reduced proteinuria in a dose-dependent manner, with high doses showing efficacy similar to that of clinically used irbesartan.
Conclusions
Qingyu formula protects against high glucose-induced renal injury by suppressing ferroptosis via the activation of the Nrf2/SLC7A11/GPX4 pathway. These findings support QYF as a promising candidate for targeting ferroptosis in DKD. Future studies should identify its active constituents and evaluate its efficacy in clinical trials.
{"title":"Qingyu formula inhibits ferroptosis in HK-2 cells and in a diabetic nephropathy mouse model via the Nrf2/SLC7A11/GPX4 pathway","authors":"Jie Liu , Yuan-Yuan Xu , Tian-Ye Gao","doi":"10.1016/j.tice.2025.103236","DOIUrl":"10.1016/j.tice.2025.103236","url":null,"abstract":"<div><h3>Background</h3><div>Diabetic kidney disease (DKD) is a severe microvascular complication, and ferroptosis is a major contributor to its pathogenesis. This study investigated the protective effects of Qingyu formula (QYF), a traditional Chinese medicine prescription, against ferroptosis in high glucose-induced renal injury.</div></div><div><h3>Methods</h3><div>In vitro, human renal tubular cells (human kidney 2 [HK-2]) under high glucose conditions were treated with QYF. In vivo, the induced diabetic mice received QYF interventions. Biochemical and molecular assays assessed cell viability, oxidative stress, ferroptosis markers (Fe²⁺, glutathione [GSH], malondialdehyde) and nuclear factor erythroid 2-related factor 2/solute carrier family 7 member 11/glutathione peroxidase 4 (Nrf2/SLC7A11/GPX4) pathway activity.</div></div><div><h3>Results</h3><div>Qingyu formula enhanced cell viability and reduced reactive oxygen species in high glucose-treated HK-2 cells. It mitigated ferroptosis by decreasing Fe²⁺ accumulation and increasing GSH levels both in vivo and in vitro. Mechanistically, QYF upregulated GPX4, Nrf2 and SLC7A11. In diabetic mice, it improved metabolic parameters and reduced proteinuria in a dose-dependent manner, with high doses showing efficacy similar to that of clinically used irbesartan.</div></div><div><h3>Conclusions</h3><div>Qingyu formula protects against high glucose-induced renal injury by suppressing ferroptosis via the activation of the Nrf2/SLC7A11/GPX4 pathway. These findings support QYF as a promising candidate for targeting ferroptosis in DKD. Future studies should identify its active constituents and evaluate its efficacy in clinical trials.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103236"},"PeriodicalIF":2.5,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145757786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.tice.2025.103254
Mingqiang Shen , Qingqing Sun , Jinjiao Zhang , Tengfang Zhang , Lei Zhang
Non-small cell lung cancer (NSCLC), a major subtype of lung cancer, is one of the leading causes of cancer-related mortality worldwide. Succinylation has been implicated in the pathogenesis of NSCLC at the molecular level. The succinyltransferase lysine acetyltransferase 2 A (KAT2A) exhibits oncogenic properties in diverse cancers; however, its role in NSCLC development remains unclear. This study employed bioinformatics techniques, clinical specimens, and NSCLC cell lines to analyze KAT2A expression. Cell malignancy was assessed using the cell counting kit-8 (CCK-8) and colony-formation assays. Glycolytic activity was evaluated by measuring glucose uptake, lactate production, extracellular acidification rate, and oxygen consumption rate. The underlying mechanisms were explored using quantitative real-time polymerase chain reaction, immunoblotting, immunoprecipitation, immunofluorescence, and cycloheximide chase assays. The results showed that KAT2A expression was notably higher in NSCLC and was linked to poor prognosis. Knockdown of KAT2A suppressed NSCLC cell growth and glycolysis. Mechanistically, KAT2A knockdown reduced the succinylation of transforming growth factor beta receptor 2 (TGFβR2) at lysine 493, leading to decreased expression of TGFβR2. A mutation at this site attenuated the oncogenic and glycolytic effects induced by TGFβR2 overexpression. Moreover, in vivo experiments demonstrated that KAT2A knockdown markedly inhibited tumor growth. Our findings suggest that KAT2A functions as an oncogenic driver in NSCLC by modulating the succinylation of TGFβR2, underscoring its potential as a therapeutic target.
非小细胞肺癌(NSCLC)是肺癌的一个主要亚型,是全球癌症相关死亡的主要原因之一。琥珀酰化在分子水平上与非小细胞肺癌的发病机制有关。琥珀基转移酶赖氨酸乙酰转移酶2 A (KAT2A)在多种癌症中表现出致癌特性;然而,其在非小细胞肺癌发展中的作用尚不清楚。本研究采用生物信息学技术、临床标本和NSCLC细胞系分析KAT2A的表达。使用细胞计数试剂盒-8 (CCK-8)和集落形成试验评估细胞恶性。糖酵解活性通过测量葡萄糖摄取、乳酸生成、细胞外酸化速率和氧气消耗速率来评估。利用实时定量聚合酶链反应、免疫印迹、免疫沉淀、免疫荧光和环己亚胺追踪法探索其潜在机制。结果显示,KAT2A在NSCLC中的表达明显升高,且与预后不良有关。KAT2A敲低抑制NSCLC细胞生长和糖酵解。机制上,KAT2A敲低可降低转化生长因子β受体2 (TGFβR2)在赖氨酸493位点的琥珀酰化,导致TGFβR2表达降低。该位点的突变减弱了TGFβR2过表达诱导的致癌和糖酵解作用。此外,体内实验表明,KAT2A敲低可显著抑制肿瘤生长。我们的研究结果表明,KAT2A通过调节TGFβR2的琥珀酰化,在非小细胞肺癌中发挥致癌驱动作用,强调了其作为治疗靶点的潜力。
{"title":"KAT2A accelerates lung cancer progression through succinylation of TGFβR2","authors":"Mingqiang Shen , Qingqing Sun , Jinjiao Zhang , Tengfang Zhang , Lei Zhang","doi":"10.1016/j.tice.2025.103254","DOIUrl":"10.1016/j.tice.2025.103254","url":null,"abstract":"<div><div>Non-small cell lung cancer (NSCLC), a major subtype of lung cancer, is one of the leading causes of cancer-related mortality worldwide. Succinylation has been implicated in the pathogenesis of NSCLC at the molecular level. The succinyltransferase lysine acetyltransferase 2 A (KAT2A) exhibits oncogenic properties in diverse cancers; however, its role in NSCLC development remains unclear. This study employed bioinformatics techniques, clinical specimens, and NSCLC cell lines to analyze KAT2A expression. Cell malignancy was assessed using the cell counting kit-8 (CCK-8) and colony-formation assays. Glycolytic activity was evaluated by measuring glucose uptake, lactate production, extracellular acidification rate, and oxygen consumption rate. The underlying mechanisms were explored using quantitative real-time polymerase chain reaction, immunoblotting, immunoprecipitation, immunofluorescence, and cycloheximide chase assays. The results showed that KAT2A expression was notably higher in NSCLC and was linked to poor prognosis. Knockdown of KAT2A suppressed NSCLC cell growth and glycolysis. Mechanistically, KAT2A knockdown reduced the succinylation of transforming growth factor beta receptor 2 (TGFβR2) at lysine 493, leading to decreased expression of TGFβR2. A mutation at this site attenuated the oncogenic and glycolytic effects induced by TGFβR2 overexpression. Moreover, <em>in vivo</em> experiments demonstrated that KAT2A knockdown markedly inhibited tumor growth. Our findings suggest that KAT2A functions as an oncogenic driver in NSCLC by modulating the succinylation of TGFβR2, underscoring its potential as a therapeutic target.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103254"},"PeriodicalIF":2.5,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.tice.2025.103250
Byungyoon Choi , Yoon Seok Jung , Woo-Ram Park , Yong-Hoon Kim , Chul-Ho Lee , Hueng-Sik Choi , Don-Kyu Kim
Estrogen-related receptor γ (ERRγ) is a nuclear receptor and transcription factor that plays an important role in liver metabolism by regulating the transcription of genes involved in inflammation, alcohol metabolism, and iron metabolism. Lipocalin 2 (LCN2) is a secreted protein that regulates inflammation, immune response, and iron homeostasis and is involved in liver injury. However, the transcriptional regulation of LCN2 in the liver remains largely unknown. Here, we showed that ERRγ is a critical transcriptional regulator of the hepatic LCN2 gene in carbon tetrachloride (CCl4)-induced acute liver injury. CCl4 treatment significantly increased hepatic ERRγ and LCN2 gene expression by inducing interleukin-6 (IL-6) expression in mice. Interestingly, ERRγ overexpression increased LCN2 gene expression and secretion in the livers of mice. Conversely, mice with the liver-specific knockout of ERRγ (ERRγ-LKO) exhibited significantly decreased CCl4-induced LCN2 gene expression in the liver. Moreover, IL-6 treatment increased LCN2 expression and secretion in the livers of wild-type mice, which was significantly attenuated in ERRγ-LKO mice. Furthermore, deletion and mutation analyses revealed that ERRγ directly binds to ERR-response elements in the LCN2 promoter, modulating LCN2 gene transcription; these data were confirmed by a chromatin immunoprecipitation assay. Finally, administering GSK5182, an inverse agonist of ERRγ, significantly reduced the CCl4-induced levels of LCN2 mRNA and protein in the liver. These findings suggest that ERRγ is a previously unrecognized transcriptional regulator of LCN2 in CCl4-mediated acute liver injury.
{"title":"Nuclear receptor ERRγ acts as a key transcriptional regulator of hepatic LCN2 expression in CCl4-induced acute liver injury","authors":"Byungyoon Choi , Yoon Seok Jung , Woo-Ram Park , Yong-Hoon Kim , Chul-Ho Lee , Hueng-Sik Choi , Don-Kyu Kim","doi":"10.1016/j.tice.2025.103250","DOIUrl":"10.1016/j.tice.2025.103250","url":null,"abstract":"<div><div>Estrogen-related receptor γ (ERRγ) is a nuclear receptor and transcription factor that plays an important role in liver metabolism by regulating the transcription of genes involved in inflammation, alcohol metabolism, and iron metabolism. Lipocalin 2 (LCN2) is a secreted protein that regulates inflammation, immune response, and iron homeostasis and is involved in liver injury. However, the transcriptional regulation of LCN2 in the liver remains largely unknown. Here, we showed that ERRγ is a critical transcriptional regulator of the hepatic <em>LCN2</em> gene in carbon tetrachloride (CCl<sub>4</sub>)-induced acute liver injury. CCl<sub>4</sub> treatment significantly increased hepatic <em>ERRγ</em> and <em>LCN2</em> gene expression by inducing interleukin-6 (IL-6) expression in mice. Interestingly, ERRγ overexpression increased <em>LCN2</em> gene expression and secretion in the livers of mice. Conversely, mice with the liver-specific knockout of ERRγ (ERRγ-LKO) exhibited significantly decreased CCl<sub>4</sub>-induced <em>LCN2</em> gene expression in the liver. Moreover, IL-6 treatment increased <em>LCN2</em> expression and secretion in the livers of wild-type mice, which was significantly attenuated in ERRγ-LKO mice. Furthermore, deletion and mutation analyses revealed that ERRγ directly binds to ERR-response elements in the <em>LCN2</em> promoter, modulating <em>LCN2</em> gene transcription; these data were confirmed by a chromatin immunoprecipitation assay. Finally, administering GSK5182, an inverse agonist of ERRγ, significantly reduced the CCl<sub>4</sub>-induced levels of LCN2 mRNA and protein in the liver. These findings suggest that ERRγ is a previously unrecognized transcriptional regulator of <em>LCN2</em> in CCl<sub>4</sub>-mediated acute liver injury.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103250"},"PeriodicalIF":2.5,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.tice.2025.103251
Yu Ruida , Rong Siyu , Qi Yufei , A. Shahbaz , Sh. Baghaei
Microfluidics is the science and technology of systems that process tiny amounts of fluid using channels with dimensions ranging from 10 to 100 micrometers. This field addresses the behavior, precise control, and maintenance of fluids geometrically constrained to small scales, typically below the millimeter range. Microfluidic systems collaborate with various disciplines to design diverse applications. Microfluidics is inherently interdisciplinary, encompassing fields such as medicine, physics, biology, materials science, mechanical engineering, and electronics. Key drivers of microfluidics include molecular analysis, biosafety, molecular biology, and microelectronics. Microchannels can be fabricated on various substrates, including glass, polymers, plastics, ceramics, and metals. Fluid behavior at the micro-scale differs from the macro-scale due to low thermal mass and high surface-to-volume ratios, leading to rapid heat transfer and precise temperature control. Significant advancements in microfluidics were limited until recent decades, when researchers conducted extensive studies to develop new microfluidic components. This work employs Finite Element Analysis (FEA) to model fluid dynamics in key microfluidic systems. Complementarily, a statistical analysis of design parameters quantifies a critical performance trade-off, providing a data-driven framework for optimizing devices towards either high-throughput efficiency or high-precision measurement for targeted applications in sports medicine. The Lab-on-a-Chip (LOC) paradigm represents an integrative framework of cohesive unit operations engineered to provide precise, expedient, and efficient control within biological and chemical domains. Microfluidic technology holds immense potential to revolutionize healthcare, from diagnostics and therapeutics to regenerative and sport medicine. As a result, microfluidic technologies are set to revolutionize sports medicine, fostering a new era of tailored health management and sport performance optimization.
{"title":"Innovative approaches for microfluidics techniques in tissue engineering and revolutionizing sports medicine: Enhancing athletic performance and recovery using finite element and statistical analysis","authors":"Yu Ruida , Rong Siyu , Qi Yufei , A. Shahbaz , Sh. Baghaei","doi":"10.1016/j.tice.2025.103251","DOIUrl":"10.1016/j.tice.2025.103251","url":null,"abstract":"<div><div>Microfluidics is the science and technology of systems that process tiny amounts of fluid using channels with dimensions ranging from 10 to 100 micrometers. This field addresses the behavior, precise control, and maintenance of fluids geometrically constrained to small scales, typically below the millimeter range. Microfluidic systems collaborate with various disciplines to design diverse applications. Microfluidics is inherently interdisciplinary, encompassing fields such as medicine, physics, biology, materials science, mechanical engineering, and electronics. Key drivers of microfluidics include molecular analysis, biosafety, molecular biology, and microelectronics. Microchannels can be fabricated on various substrates, including glass, polymers, plastics, ceramics, and metals. Fluid behavior at the micro-scale differs from the macro-scale due to low thermal mass and high surface-to-volume ratios, leading to rapid heat transfer and precise temperature control. Significant advancements in microfluidics were limited until recent decades, when researchers conducted extensive studies to develop new microfluidic components. This work employs Finite Element Analysis (FEA) to model fluid dynamics in key microfluidic systems. Complementarily, a statistical analysis of design parameters quantifies a critical performance trade-off, providing a data-driven framework for optimizing devices towards either high-throughput efficiency or high-precision measurement for targeted applications in sports medicine. The Lab-on-a-Chip (LOC) paradigm represents an integrative framework of cohesive unit operations engineered to provide precise, expedient, and efficient control within biological and chemical domains. Microfluidic technology holds immense potential to revolutionize healthcare, from diagnostics and therapeutics to regenerative and sport medicine. As a result, microfluidic technologies are set to revolutionize sports medicine, fostering a new era of tailored health management and sport performance optimization.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103251"},"PeriodicalIF":2.5,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.tice.2025.103253
Zhaojie Li , Jianqiang Zhao
Background
Abnormal methylation of protein arginine can cause dysfunction of cardiomyocytes, it is important to further elucidate the molecular mechanism.
Method
Candidate protein arginine methyltransferases (PRMTs) were selected using blood samples of myocardial infarction (MI) and control group. The isolated primary cardiomyocyte (PC) and H9C2 cells were treated with H2O2 to mimic MI in vitro and rats with myocardial ischemia-reperfusion (I/R) were established to mimic MI in vivo. The protein content of PRMT1 methylation product P53 was detected to reflect the PRMT1 activity.
Result
PRMT1 was aberrant upregulated in MI models. PRMT1 ablation suppressed cell apoptosis and inflammatory cytokine secretion to reverse the H2O2 function. The upregulation of PRMT1 accelerated the degradation of P53 protein through the arginine methylation. Inhibition of PRMT1 alleviated cardiac damage after I/R in rats.
Conclusion
PRMT1 promoted MI by mediating arginine methylation of P53. PRMT1 may be a promising therapeutic target for MI.
{"title":"PRMT1 promotes H2O2 induced cardiomyocytes cell via mediating arginine methylation of P53","authors":"Zhaojie Li , Jianqiang Zhao","doi":"10.1016/j.tice.2025.103253","DOIUrl":"10.1016/j.tice.2025.103253","url":null,"abstract":"<div><h3>Background</h3><div>Abnormal methylation of protein arginine can cause dysfunction of cardiomyocytes, it is important to further elucidate the molecular mechanism.</div></div><div><h3>Method</h3><div>Candidate protein arginine methyltransferases (PRMTs) were selected using blood samples of myocardial infarction (MI) and control group. The isolated primary cardiomyocyte (PC) and H9C2 cells were treated with H<sub>2</sub>O<sub>2</sub> to mimic MI <em>in vitro</em> and rats with myocardial ischemia-reperfusion (I/R) were established to mimic MI <em>in vivo.</em> The protein content of PRMT1 methylation product P53 was detected to reflect the PRMT1 activity.</div></div><div><h3>Result</h3><div>PRMT1 was aberrant upregulated in MI models. PRMT1 ablation suppressed cell apoptosis and inflammatory cytokine secretion to reverse the H<sub>2</sub>O<sub>2</sub> function. The upregulation of PRMT1 accelerated the degradation of P53 protein through the arginine methylation. Inhibition of PRMT1 alleviated cardiac damage after I/R in rats.</div></div><div><h3>Conclusion</h3><div>PRMT1 promoted MI by mediating arginine methylation of P53. PRMT1 may be a promising therapeutic target for MI.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103253"},"PeriodicalIF":2.5,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25DOI: 10.1016/j.tice.2025.103242
Yanfei Yang, Lili Yang, Yabin Li, Yanfen Wang
Background
The gut microbiota is essential for the bidirectional communication between the gut and the brain. However, its specific role and underlying mechanisms in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis remain largely unclear.
Methods
An anti-NMDAR encephalitis model was induced by GluN1 peptide immunization, and brain histopathology was assessed by hematoxylin-eosin staining. Behavioral performance was assessed through the Y-maze and open field tests. Flow cytometry was employed to quantify T follicular helper (Tfh) and T follicular regulatory (Tfr) cell populations. Enzyme-linked immunosorbent assay and western blot were used to assess inflammatory cytokines and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway-related protein levels, respectively. 16S rRNA sequencing and Helicobacter rodentium gavage (1.5 mL, 1 ×10 ¹¹ CFU/mL) were used to assess microbiota composition and bacterial function.
Results
16S rRNA sequencing revealed a trend toward reduced gut microbial diversity in anti-NMDAR encephalitis mice. Helicobacter rodentium colonization further exacerbated behavioral deficits and inflammatory cell infiltration in the cerebral cortex. This was accompanied by a marked increase in tumor necrosis factor alpha (TNF-α) and interleukin (IL)-21 levels and a reduction in IL-10 concentrations in both cerebrospinal fluid and serum. Moreover, the Tfh/Tfr cell ratio was further elevated following Helicobacter rodentium exposure. Targeted suppression of the PI3K/AKT pathway with LY294002 significantly restored Tfh/Tfr balance and alleviated neurobehavioral impairments and cortical inflammation.
Conclusion
Helicobacter rodentium exacerbates anti-NMDAR encephalitis by inducing PI3K/AKT-mediated Tfh/Tfr imbalance, highlighting a potential therapeutic target in autoimmune encephalitis.
{"title":"Gut-derived Helicobacter rodentium aggravates Tfh/Tfr imbalance and neuroinflammation via PI3K/AKT activation in anti-NMDAR encephalitis mice","authors":"Yanfei Yang, Lili Yang, Yabin Li, Yanfen Wang","doi":"10.1016/j.tice.2025.103242","DOIUrl":"10.1016/j.tice.2025.103242","url":null,"abstract":"<div><h3>Background</h3><div>The gut microbiota is essential for the bidirectional communication between the gut and the brain. However, its specific role and underlying mechanisms in anti-N-methyl-<span>D</span>-aspartate receptor (NMDAR) encephalitis remain largely unclear.</div></div><div><h3>Methods</h3><div>An anti-NMDAR encephalitis model was induced by GluN1 peptide immunization, and brain histopathology was assessed by hematoxylin-eosin staining. Behavioral performance was assessed through the Y-maze and open field tests. Flow cytometry was employed to quantify T follicular helper (Tfh) and T follicular regulatory (Tfr) cell populations. Enzyme-linked immunosorbent assay and western blot were used to assess inflammatory cytokines and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway-related protein levels, respectively. 16S rRNA sequencing and <em>Helicobacter rodentium</em> gavage (1.5 mL, 1 ×10 ¹¹ CFU/mL) were used to assess microbiota composition and bacterial function.</div></div><div><h3>Results</h3><div>16S rRNA sequencing revealed a trend toward reduced gut microbial diversity in anti-NMDAR encephalitis mice. <em>Helicobacter rodentium</em> colonization further exacerbated behavioral deficits and inflammatory cell infiltration in the cerebral cortex. This was accompanied by a marked increase in tumor necrosis factor alpha (TNF-α) and interleukin (IL)-21 levels and a reduction in IL-10 concentrations in both cerebrospinal fluid and serum. Moreover, the Tfh/Tfr cell ratio was further elevated following <em>Helicobacter rodentium</em> exposure. Targeted suppression of the PI3K/AKT pathway with LY294002 significantly restored Tfh/Tfr balance and alleviated neurobehavioral impairments and cortical inflammation.</div></div><div><h3>Conclusion</h3><div><em>Helicobacter rodentium</em> exacerbates anti-NMDAR encephalitis by inducing PI3K/AKT-mediated Tfh/Tfr imbalance, highlighting a potential therapeutic target in autoimmune encephalitis.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103242"},"PeriodicalIF":2.5,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.tice.2025.103248
Changdong Fan , Jing Ma , Fengliang Fan , Rongbing Yi , Wenbo Wang
Background and aims
Ferroptosis has been acknowledged to be involved in the progression of osteoarthritis (OA), contributing to chondrocyte damage and articular cartilage degradation. This investigation seeks to explain the mechanism of RBM15 in ferroptosis of OA cell models.
Methods
OA cell model was established using IL-1β-induced chondrocytes. After silencing RBM15 expression, TNF-α and IL-6 were detected, cell viability was measured, LDH, Fe²⁺, ROS, MDA, and GSH were assessed, and ACSL4 and SLC7A11 expression was quantified. RT-qPCR and Western blot were employed to detect the expression of RBM15, KDM2A, and HOXA2. The m6A content in cells was assayed using a kit. RIP assay was utilized to analyze m6A modification on KDM2A. Dual-luciferase assay was employed to validate RBM15-mediated m6A modification on KDM2A. RT-qPCR was applied to examine KDM2A mRNA stability. ChIP was employed to assess the enrichment of KDM2A and H3K36me2 at the HOXA2 promoter. Combined experiments were designed to elucidate the role of KDM2A and HOXA2 in ferroptosis of OA cell models.
Results
RBM15 and KDM2A were upregulated, while HOXA2 was reduced in IL-1β-stimulated chondrocytes. RBM15 downregulation enhanced chondrocyte viability and mitigated ferroptosis. RBM15-mediated m6A modification upregulated KDM2A, suppressed H3K36me2 enrichment at the HOXA2 promoter, and inhibited HOXA2 expression. Overexpression of KDM2A and downregulation of HOXA2 could partially counteract the suppressive effect of RBM15 silencing on chondrocyte ferroptosis.
Conclusion
RBM15-mediated m6A modification upregulates KDM2A to inhibit HOXA2 expression by reducing H3K36me2 enrichment, thus promoting IL-1β-induced chondrocyte ferroptosis.
{"title":"RBM15-mediated m6A modification upregulates KDM2A to promote ferroptosis in osteoarthritis cells","authors":"Changdong Fan , Jing Ma , Fengliang Fan , Rongbing Yi , Wenbo Wang","doi":"10.1016/j.tice.2025.103248","DOIUrl":"10.1016/j.tice.2025.103248","url":null,"abstract":"<div><h3>Background and aims</h3><div>Ferroptosis has been acknowledged to be involved in the progression of osteoarthritis (OA), contributing to chondrocyte damage and articular cartilage degradation. This investigation seeks to explain the mechanism of RBM15 in ferroptosis of OA cell models.</div></div><div><h3>Methods</h3><div>OA cell model was established using IL-1β-induced chondrocytes. After silencing RBM15 expression, TNF-α and IL-6 were detected, cell viability was measured, LDH, Fe²⁺, ROS, MDA, and GSH were assessed, and ACSL4 and SLC7A11 expression was quantified. RT-qPCR and Western blot were employed to detect the expression of RBM15, KDM2A, and HOXA2. The m6A content in cells was assayed using a kit. RIP assay was utilized to analyze m6A modification on KDM2A. Dual-luciferase assay was employed to validate RBM15-mediated m6A modification on KDM2A. RT-qPCR was applied to examine KDM2A mRNA stability. ChIP was employed to assess the enrichment of KDM2A and H3K36me2 at the HOXA2 promoter. Combined experiments were designed to elucidate the role of KDM2A and HOXA2 in ferroptosis of OA cell models.</div></div><div><h3>Results</h3><div>RBM15 and KDM2A were upregulated, while HOXA2 was reduced in IL-1β-stimulated chondrocytes. RBM15 downregulation enhanced chondrocyte viability and mitigated ferroptosis. RBM15-mediated m6A modification upregulated KDM2A, suppressed H3K36me2 enrichment at the HOXA2 promoter, and inhibited HOXA2 expression. Overexpression of KDM2A and downregulation of HOXA2 could partially counteract the suppressive effect of RBM15 silencing on chondrocyte ferroptosis.</div></div><div><h3>Conclusion</h3><div>RBM15-mediated m6A modification upregulates KDM2A to inhibit HOXA2 expression by reducing H3K36me2 enrichment, thus promoting IL-1β-induced chondrocyte ferroptosis.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103248"},"PeriodicalIF":2.5,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.tice.2025.103245
Hongfang Gong , Yaping Song , Dongmei Yang , Chao Jiang , Ruopu Jiao , Yilun Ma , Sayed Haidar Abbas Raza , Jiupan Zhang , Dawei Wei
The coordinated development of skeletal muscle and intramuscular adipose tissue in animals essentially determines meat yield and quality, a process co-regulated by multiple genes. Using a co-culture model of bovine skeletal muscle cells (SMCs) and intramuscular adipocytes (IMAs), integrated with transcriptomic sequencing and bioinformatic analyses, key candidate genes coregulating muscle development and fat deposition were identified. Three potential coregulators—WNT5A, APOE, and BDKRB2—were selected. Protein-protein interaction (PPI) network analysis, along with tissue and cellular expression profiling, indicates that WNT5A potentially interacts with key protein markers of adipogenesis and myogenesis. Furthermore, it is highly expressed in both adipose and muscle tissues. Pathway enrichment analysis revealed significant enrichment of WNT5A in the Wnt signaling pathway. These findings suggest that WNT5A plays a dual regulatory role in the development of both skeletal muscle and intramuscular fat (IMF). This finding lays a solid theoretical foundation for deciphering the molecular mechanisms of muscle-fat deposition in beef cattle and for improving meat quality.
{"title":"Analysis of WNT5A as a key regulator of intramuscular fat deposition in muscle-adipocyte co-cultures","authors":"Hongfang Gong , Yaping Song , Dongmei Yang , Chao Jiang , Ruopu Jiao , Yilun Ma , Sayed Haidar Abbas Raza , Jiupan Zhang , Dawei Wei","doi":"10.1016/j.tice.2025.103245","DOIUrl":"10.1016/j.tice.2025.103245","url":null,"abstract":"<div><div>The coordinated development of skeletal muscle and intramuscular adipose tissue in animals essentially determines meat yield and quality, a process co-regulated by multiple genes. Using a co-culture model of bovine skeletal muscle cells (SMCs) and intramuscular adipocytes (IMAs), integrated with transcriptomic sequencing and bioinformatic analyses, key candidate genes coregulating muscle development and fat deposition were identified. Three potential coregulators—<em>WNT5A</em>, <em>APOE</em>, and <em>BDKRB2</em>—were selected. Protein-protein interaction (PPI) network analysis, along with tissue and cellular expression profiling, indicates that WNT5A potentially interacts with key protein markers of adipogenesis and myogenesis. Furthermore, it is highly expressed in both adipose and muscle tissues. Pathway enrichment analysis revealed significant enrichment of <em>WNT5A</em> in the Wnt signaling pathway. These findings suggest that <em>WNT5A</em> plays a dual regulatory role in the development of both skeletal muscle and intramuscular fat (IMF). This finding lays a solid theoretical foundation for deciphering the molecular mechanisms of muscle-fat deposition in beef cattle and for improving meat quality.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103245"},"PeriodicalIF":2.5,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}